Immunoassays
News on immunoassay systems and applications.
EDX Medical Launches High-Sensitivity Test for Testicular Cancer Early Detection, Monitoring
Premium
The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.
IL-6 outperformed traditional sepsis biomarkers like C-reactive protein and procalcitonin in the cohorts.
Investment firm Kent Lake said the securities deal, which is linked to the firm's planned acquisition of Akoya, is "backdoor financing" and "highly unfavorable to Quanterix shareholders."
The loss of funding appears poised to impact disease spread, resistance, and death rates, in part through its impact on diagnostic testing.
The company said it expects its first quarter revenue to be down 10 percent to 15 percent year over year due in part to a decline in US academic sales.